NEW YORK (TheStreet) -- Merit Medical Systems (Nasdaq:MMSI) hit a new 52-week high Wednesday as it traded at $18.17 compared with its previous 52-Week high of $18.15. Merit Medical Systems is changing hands at $18.17 with 67,405 shares traded as of 12:46 p.m. ET. Average volume has been 159,000 shares over the past 30 days. Merit Medical Systems has a market cap of $507.4 million and is part of the health care sector and health services industry. Shares are up 13.7% year to date as of the close of trading on Tuesday. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company's cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions. The company has a P/E ratio of 20.6, below the average health services industry P/E ratio of 41.7 and above the S&P 500 P/E ratio of 16. TheStreet Ratings rates Merit Medical Systems as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. You can view the full Merit Medical Systems Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
Latest Headlines about MMSI
Latest from TheStreet Wire
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV